OQROGet OQRO Pro
Insider trade

Mineralys Therapeutics (MLYS)CEO sold ~$1.91M

Jon Congleton, CEO at Mineralys Therapeutics, sold ~$1.91M of Mineralys Therapeutics shares.

~$1.91M
Approx. value · 75K sh @ $25.46
529K
Holds after · shares reported
Traded
Sep 30, 2026
Filed
Oct 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 5, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On August 5, 2026, the Company’s Board of Directors (the Board) appointed James J. Ferguson III, M.D., as the Company’s new Chief Medical Officer, effective August 10, 2026, replacing David Rodman, M.D., who remains with the Company on a full-time basis as a Strategic Advisor.”
  2. Sep 22, 2026InsiderDirector sold ~$3.01M of MLYS shares in the open market
  3. Sep 30, 2026 · this disclosureInsider · Their largest sale since 2024CEO sold ~$1.91M of MLYS shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Mineralys Therapeutics

For Mineralys Therapeutics, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MLYS page.

Other recent filings by Jon Congleton, Chief Executive Officer

The full history of Jon Congleton, Chief Executive Officer is on the profile page.

How this filing works

Other disclosures at Mineralys Therapeutics

Everything OQRO holds on this company is on its MLYS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data